S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
Completed · Phase 2
Conditions studied: Extrahepatic Bile Duct Cancer, Gallbladder Cancer
In brief
RATIONALE: Drugs used in chemotherapy, such as capecitabine and gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Giving more than one drug (combination chemotherapy) together with radiation therapy may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving capecitabine together with gemcitabine followed by capecitabine and radiation therapy works in treating patients with cholangiocarcinoma of the gallbladder or bile duct.
Key facts
- Study ID
- NCT00789958
- Run by
- SWOG Cancer Research Network
- People needed
- 105
- Starts
- 2008-12-01
- Expected to finish
- 2017-12-01
- Last updated by the study team
- 2018-04-09
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
- Alta Bates Summit Comprehensive Cancer Center — Berkeley, California, United States
- Peninsula Medical Center — Burlingame, California, United States
- Rebecca and John Moores UCSD Cancer Center — La Jolla, California, United States
- Kaiser Permanente Medical Center - Los Angeles — Los Angeles, California, United States
- USC/Norris Comprehensive Cancer Center and Hospital — Los Angeles, California, United States
- Sutter Health - Western Division Cancer Research Group — Novato, California, United States
- Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center — Orange, California, United States
- California Pacific Medical Center - California Campus — San Francisco, California, United States
- Sutter Pacific Medical Foundation — Santa Rosa, California, United States
- Sutter Solano Medical Center — Vallejo, California, United States
- Aurora Presbyterian Hospital — Aurora, Colorado, United States
- University of Colorado Cancer Center at UC Health Sciences Center — Aurora, Colorado, United States
- Boulder Community Hospital — Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital — Colorado Springs, Colorado, United States
- St. Anthony Central Hospital — Denver, Colorado, United States
- Porter Adventist Hospital — Denver, Colorado, United States
- Presbyterian - St. Luke's Medical Center — Denver, Colorado, United States
- St. Joseph Hospital — Denver, Colorado, United States
- Rose Medical Center — Denver, Colorado, United States
- CCOP - Colorado Cancer Research Program — Denver, Colorado, United States
- Shaw Regional Cancer Center — Edwards, Colorado, United States
- Swedish Medical Center — Englewood, Colorado, United States
- St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center — Grand Junction, Colorado, United States
- Regional Medical Center — Anniston, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.